1. Home
  2. FPI vs PHAR Comparison

FPI vs PHAR Comparison

Compare FPI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.82

Market Cap

448.2M

Sector

Real Estate

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$17.13

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
PHAR
Founded
2013
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.2M
1.1B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
FPI
PHAR
Price
$9.82
$17.13
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$38.00
AVG Volume (30 Days)
633.0K
23.0K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
2.41%
N/A
EPS Growth
296.76
N/A
EPS
1.27
0.00
Revenue
$52,990,000.00
$362,274,000.00
Revenue This Year
N/A
$25.19
Revenue Next Year
N/A
$4.47
P/E Ratio
$7.82
$3,089.47
Revenue Growth
N/A
26.78
52 Week Low
$9.37
$7.50
52 Week High
$12.87
$18.12

Technical Indicators

Market Signals
Indicator
FPI
PHAR
Relative Strength Index (RSI) 43.27 54.31
Support Level $9.65 $16.15
Resistance Level $10.53 $17.00
Average True Range (ATR) 0.15 0.76
MACD -0.00 -0.06
Stochastic Oscillator 11.88 53.81

Price Performance

Historical Comparison
FPI
PHAR

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: